Advertisements

Zestril 5mg

Quick links to important sections

Zestril 5mg

Advertisements
Advertisements

Treatment option:

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Zestril 5mg

Property Description
Active Ingredient Lisinopril (as dihydrate salt)
Form Oral Tablet (solid dosage form)
Pharmacological Class Angiotensin-Converting Enzyme (ACE) Inhibitor
Origin Synthetic Peptide Derivative

What Type of Medicine is Zestril 5mg?

Zestril 5mg is a prescription-only medicine in the form of an oral tablet that contains the active ingredient Lisinopril in a specific five-milligram strength. Pharmacologically, it is classified as an Angiotensin-Converting Enzyme (ACE) Inhibitor, placing it within the broader group of Antihypertensive Agents.

This medication’s identity is rooted in the Lisinopril compound, a synthetic peptide derivative formulated for daily ingestion. Lisinopril is an orally active, long-acting agent that is not a prodrug, a characteristic clinically recognized for simplifying its pharmacokinetic profile. The brand Zestril is a widely known trade name for this formulation, often used alongside other commercial brands containing Lisinopril, such as Prinivil.


Composition and Action in the Circulatory System

The core composition of this medication is the Lisinopril compound, which functions by blocking the action of the Angiotensin-Converting Enzyme (ACE). Its primary role is to influence the body’s cardiovascular dynamics by interfering with a key hormonal process.

This pharmacological action targets the Renin-Angiotensin-Aldosterone System (RAAS), a crucial mechanism that regulates fluid balance and vessel tone. By inhibiting the ACE, the drug prevents the formation of the powerful hormone Angiotensin II, which causes blood vessels to narrow. This intervention promotes vasodilation, which is the widening and relaxation of the blood vessels. This mechanism supports the relaxation of blood vessels and helps to lower blood pressure.


The General Purpose of Lisinopril

The general purpose of taking a medication like Zestril 5mg is to help maintain stable, healthy blood pressure and support the efficiency of the circulatory system over the long term.

By facilitating easier and less restricted blood flow throughout the body, the overall workload on the heart is significantly reduced. This systematic effect is the core benefit of the medication, contributing to the functional stability of the patient's cardiovascular performance by managing systemic resistance and fluid dynamics.

Regulatory References

  1. NIH StatPearls: Lisinopril Mechanism
Advertisements

What side effects are possible with Zestril 5mg?

Possible Side Effects and Safety Information

The safety profile for Zestril (lisinopril) is officially documented by government regulatory authorities, classifying possible adverse reactions by frequency and the body system affected. This information provides a neutral, label-based overview of the drug's safety characteristics.

Frequency-Classified Adverse Reactions

The most frequently reported adverse reactions, classified as Common (occurring in ge 1/100 to < 1/10 of patients) in regulatory documents, include headache, dizziness, cough, diarrhea, vomiting, and fatigue. Effects on the cardiovascular system, such as orthostatic hypotension (dizziness upon standing), are also common. Reactions classified as Uncommon include mood alterations, taste disturbance, and various skin rashes.

Serious Adverse Reactions and System-Organ Concerns

The official labeling highlights the potential for serious adverse reactions, notably Angioedema, which involves swelling of the face, extremities, lips, tongue, or throat, and is considered a life-threatening event. Other rare, but serious, effects affecting organ systems include Acute Renal Failure and hepatic disorders like jaundice. The characteristic cough associated with this class of medicine affects the respiratory system.

Safety Constraints and Population Notes

Official documents define specific safety constraints. A history of Angioedema related to any previous ACE inhibitor use is a major constraint. Furthermore, the medication is contraindicated during the second and third trimesters of pregnancy due to the risk of fetal injury. Certain effects, such as hypotension, are noted as being more common at the initiation of treatment or during dose changes. The safety profile also emphasizes the need for caution in patients with underlying renal impairment.

Advertisements

Overdose and Emergency Response

The official regulatory documents state that the primary manifestation of a Zestril (Lisinopril) overdose is an excessive reduction of blood pressure, known as profound hypotension. This condition may lead to severe or life-threatening outcomes, including circulatory shock, and carries the potential risk of developing acute renal failure or significant electrolyte disturbances, such as hyperkalemia.

Given the severity of these documented risks, official guidelines mandate that individuals seek immediate medical attention for any suspected overdose. Emergency services should be contacted immediately if the person has collapsed, is experiencing trouble breathing, or cannot be awakened.

Regulatory guidance confirms that no specific antidote is known to fully reverse the effects of Lisinopril. Therefore, management focuses on general supportive care. The required procedural interventions involve initial volume expansion using an intravenous infusion of normal saline to restore blood pressure. If the hypotension remains refractory (unresponsive) to fluid therapy, the administration of vasopressors may be necessary. Lisinopril can be removed from the bloodstream using hemodialysis.

Monitoring is a mandatory component of overdose management. Symptomatic or hypotensive patients must be admitted for an observation period of at least 24 hours. Continuous monitoring of vital signs and laboratory parameters, including serum creatinine and BUN, is required to assess renal function and overall stability.

Advertisements

Therapeutic Uses of Zestril 5mg

Zestril (lisinopril) is commonly used to provide supportive therapeutic benefit in several key cardiovascular and systemic domains. This medication is relevant for managing conditions associated with increased physiological stress.

The primary therapeutic applications include the management of essential hypertension (high blood pressure), providing support for patients with chronic heart failure, and assisting in the stabilization phase following a myocardial infarction (heart attack). This medication helps address symptom clusters that may become intense or disruptive, particularly those related to systemic imbalance and physiological strain. By supporting blood pressure control, Zestril contributes to easing the overall symptom load.

“This treatment is applied across therapeutic domains to help address symptoms linked to organ-specific functional stress.”

In high-risk patients, such as those with diabetes and hypertension, the medication may also assist with managing complications that create noticeable physiological strain over time. It provides support that helps ease the overall symptom burden, assisting with maintaining functional stability.


Quick Fact: Support for Blood Pressure Stress

Zestril is commonly used to help manage symptoms related to sustained physiological strain resulting from long-term hypertension, contributing to improved day-to-day comfort.

Regulatory References

  1. NIH MedlinePlus Drug Information overview
Advertisements

Eligibility and Restrictions for Use

Who Can and Cannot Use Zestril 5mg (Lisinopril)

Official regulatory documents define strict population eligibility for Zestril 5mg (Lisinopril), identifying groups for whom use is permitted, restricted, or absolutely prohibited.


Contraindicated Populations (Must Not Use)

Contraindication Population/Condition
Angioedema History Individuals with a history of angioedema related to a previous ACE inhibitor or hereditary/idiopathic angioedema.
Pregnancy Women in the second and third trimesters. Discontinuation is required immediately upon confirmed pregnancy.
Concomitant Use Patients taking a Neprilysin Inhibitor or patients with Diabetes Mellitus taking Aliskiren.

Age and Condition Restrictions

Restriction Population/Condition
Pediatric Use Use is not recommended for children younger than six years of age. Approved for hypertension only in those six years and older.
Renal Impairment Patients with severe renal impairment (Creatinine Clearance below specific thresholds) are often not recommended or require close medical supervision.
Volume Depletion Patients with volume and salt depletion must be monitored closely upon treatment initiation due to the risk of severe hypotension.
Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

Zestril (lisinopril) has officially documented interaction patterns based primarily on pharmacodynamic reinforcement and restricted combinations as detailed in regulatory labeling.

Mandatory Prohibitions and Timing Rules

Co-administration with Sacubitril/Valsartan is formally contraindicated due to the significantly increased risk of angioedema. A strict 36-hour separation window is required between stopping one medication and starting the other. Use with Aliskiren is also contraindicated in patients with diabetes mellitus or those with renal impairment (GFR less than 60 mL/ min), reflecting the constraints of dual RAAS blockade.

Pharmacodynamic and Exposure-Altering Interactions

Interacting Substance or Class Official Documented Interaction Outcome
**Diuretics** and **Antihypertensives** Risk of **additive antihypertensive effect** (hypotension).
**Potassium-sparing Agents** (e.g., Spironolactone, Triamterene) or **Potassium Supplements** Significantly increased risk of **hyperkalemia** (high serum potassium levels).
**Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)** Risk of **attenuated antihypertensive effect** and **worsening renal function**.
**Lithium** Reversible increase in **serum lithium concentrations and toxicity**.
**mTOR Inhibitors** (e.g., Temsirolimus) Increased risk of **angioedema**.

Food/Substance Note: The risk of hyperkalemia extends to the use of potassium-containing salt substitutes. While lisinopril is primarily excreted unchanged and exhibits minimal CYP-mediated interaction, alcohol consumption may enhance the hypotensive effect.

Advertisements

Mechanism of Action

Zestril (lisinopril) functions as a competitive inhibitor of the angiotensin-converting enzyme (ACE), which is a peptidyl dipeptidase. The drug primarily targets this enzyme, which is abundant in the vascular endothelium of the lung and other tissues, thus modifying the Renin-Angiotensin-Aldosterone System (RAAS).

The core molecular pathway involves lisinopril preventing the enzymatic conversion of the inactive decapeptide angiotensin I to the potent octapeptide vasoconstrictor, angiotensin II. This inhibition consequently decreases the systemic concentration of angiotensin II.

Downstream cascades include a reduction in angiotensin II-mediated stimulation of aldosterone secretion from the adrenal cortex. This results in decreased aldosterone-dependent sodium reabsorption and water retention in the renal collecting duct. Furthermore, the removal of the negative feedback loop mediated by angiotensin II leads to an increase in plasma renin activity.

System-level physiological consequences include a reduction in peripheral arterial resistance due to decreased vasoconstrictive signaling. The net result is a systemic modulation of fluid and electrolyte balance and arterial tonus.

Advertisements

Dosage and Administration Information

Administration Guidelines for Zestril (Lisinopril)

Zestril is an oral tablet that is strictly administered once daily for all approved indications. The drug can be taken with or without food, but it is generally recommended to take the dose at the same time each day to maintain consistency.

Standard Adult Dosing Regimens

Dosing begins at a low initial strength and is gradually increased, a process known as titration, based on patient response. The usual starting dose for essential hypertension is 10 mg once daily; however, this is often reduced to 5 mg once daily if the patient is already taking a diuretic. The usual maintenance dose ranges from 20 mg to 40 mg daily, with the maximum recommended dose for hypertension being 80 mg daily.

For chronic heart failure, the recommended initial dose is 5 mg once daily, which is increased over time up to a maximum of 40 mg daily. Following an acute myocardial infarction (MI), a specific staggered sequence begins with 5 mg within 24 hours of symptoms.

Administration Rules for Specific Populations

Specific dose adjustments apply to certain patient groups:

  • Renal Impairment: For adults with reduced kidney function (creatinine clearance between 10 and 30 mL/min), the initial dose is reduced to half the usual recommended starting dose for their indication.
  • Pediatric Patients: For children aged 6 years and older, dosing is weight-based, starting at 0.07 mg per kilogram once daily, not to exceed 5 mg initially.

Missed Dose and Course Duration

If a dose is missed, it should be taken as soon as remembered, but if it is near the time of the next scheduled dose, the missed dose must be skipped; taking a double dose to compensate is not recommended. While hypertension and heart failure therapies are typically long-term, the acute MI regimen is specified to continue for at least six weeks.

Advertisements

Recent Clinical Evidence

Research Evidence / Overview of Studies for Zestril 5mg

This overview summarizes the official research base for Lisinopril (Zestril), including the types of studies conducted and what specific health outcomes were monitored. It is a strictly descriptive summary of the research landscape and does not offer any medical advice or treatment instructions.


Evidence for Use in Managing High Blood Pressure (Hypertension)

Research examining Lisinopril in the context of high blood pressure was evaluated in Randomized Controlled Trials (RCTs) and various observational cohort studies. These studies were conducted to examine the association between the medicine and changes in blood pressure over short periods of a few weeks. Studies also explored major cardiovascular events, such as heart attack and stroke, in people with mild to moderate hypertension.

Subgroup analyses from trials findings indicate a less pronounced change in blood pressure in Black patients compared to non-Black populations. Furthermore, because many RCTs focused on higher-risk individuals, existing data provides limited insight into long-term outcomes for otherwise lower-risk individuals starting therapy.


Evidence for Use in Treating Chronic Heart Failure

The research base for Lisinopril in conditions characterized by functional limitations like chronic heart failure was evaluated in long-term RCTs (such as the ATLAS trial) and extensive meta-analyses. Studies explored major clinical outcomes, including all-cause mortality, cardiovascular mortality, and the rate of hospitalization linked to heart failure.

Trials evaluated the rates of death and cardiovascular hospitalization when the observed population was compared to a control group over observation periods that lasted up to four years. Studies also monitored changes in patient-reported experiences and functional measures, such as changes in the New York Heart Association (NYHA) functional class, over the initial months of observation.


Gaps in Research and Areas of Uncertainty

While Lisinopril was evaluated in RCTs, the research landscape still contains specific gaps and areas where certainty remains low:

  • Comparative Evidence is Lacking: Some research evaluated whether positive outcomes were observed, but comparative evidence is lacking or findings were mixed across different studies when directly assessing its long-term performance against every other ACE inhibitor compound.
  • Specific Renal Populations: There is limited information for the use of Lisinopril in pediatric patients who have severe renal impairment (low GFR), meaning that the study results reflect the specific conditions under which they were conducted.

Key Studies & References

  1. Lisinopril: MedlinePlus Drug Information
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Zestril 5mg (FAQ)


Q: Why is a dry, hacking cough a common reported side effect of Zestril?

A: According to official product information, the dry cough associated with Zestril is thought to be caused by the drug's mechanism of action. By inhibiting the ACE enzyme, the medicine also slows the breakdown of a substance called bradykinin. The buildup of this substance in the airways is what is believed to trigger the persistent, non-productive cough.


Q: Is Zestril generally prescribed as a short-term or a long-term treatment?

A: For its approved uses, such as managing high blood pressure and chronic heart failure, Zestril is generally prescribed as a long-term therapy. Consistent daily use is generally associated with achieving and maintaining the intended therapeutic effects on the cardiovascular system over time.


Q: What classes of other blood pressure medications should generally be avoided while taking Zestril?

A: Regulatory documents include warnings about combining Zestril with certain other medications that also influence the Renin-Angiotensin-Aldosterone System (RAAS). This includes specific contraindications against using it with Aliskiren (in some patients) and against co-administration with a class known as Neprilysin Inhibitors.


Q: Are there any official warnings about taking Zestril and drinking alcohol?

A: Official product information notes a moderate interaction risk between Zestril and alcohol (ethanol). This is because alcohol may have additive effects in lowering blood pressure. This combination could potentially increase the risk of symptoms like lightheadedness or dizziness.


Q: Are there research themes on Zestril's role in chronic kidney disease management?

A: Studies have examined Zestril's role in supporting kidney health in specific high-risk groups. Research themes focus on the potential for ACE inhibitors to slow the worsening of kidney problems in individuals who have Type 2 diabetes and existing high blood pressure.


Q: What is the documented risk of high potassium levels (hyperkalemia) associated with Zestril?

A: High potassium levels in the blood, known as hyperkalemia, are a serious risk documented in the medicine's regulatory information. This potential effect is why patients with pre-existing kidney problems or diabetes often require close monitoring of their potassium levels while on this treatment.


Q: What is the official instruction if a dose of Zestril is missed?

A: Official administration guidelines state that if a dose is missed, it should be taken as soon as you remember. However, if it is already close to the time of your next scheduled dose, the missed dose must be skipped entirely. Taking a double dose to compensate for a missed dose is not advised in official guidelines.


Q: How is the Zestril-related cough generally described by patients?

A: Patient safety materials describe the Zestril-associated cough as typically being dry (non-productive) and persistent. The cough is often described as a constant tickle or irritation in the throat.


Q: Can Zestril 5mg cause persistent feelings of tiredness or fatigue?

A: Fatigue (tiredness) is documented as a common side effect of Zestril in official reports. While many effects lessen over time, regulatory data indicates that fatigue has been noted as one of the potential side effects that can sometimes persist long-term.


Q: Are changes in taste sensation a potential side effect of Zestril?

A: Yes, changes to the sense of taste, officially referred to as taste disturbance, are listed in the product information. This effect is classified as an uncommon adverse reaction documented in the medicine's safety profile.


Q: Is there any information on Zestril causing headaches or blurred vision?

A: Official safety information lists headache as a common side effect. Blurred vision has also been reported as a potential effect and is included in patient safety materials as a symptom that may occur.


Q: Does Zestril have documented side effects related to sexual function?

A: Official product documents list impotence or certain types of sexual dysfunction as a potential adverse effect. This effect is generally classified as an uncommon or rare event reported during clinical observation.


Q: What are the concerns about taking Zestril with medicines used to treat diabetes?

A: Official interaction warnings highlight that combining Zestril with medicines like insulin or certain oral antidiabetic agents may lead to a greater reduction in blood sugar levels. Because of this potential for enhanced effect, close monitoring is often referenced in the official product information.


Q: Are there specific instructions for what to do if a person experiences vomiting or diarrhea while taking Zestril?

A: Regulatory documents state that conditions leading to volume depletion, such as prolonged vomiting or diarrhea, are areas that require close attention. Significant fluid loss can lead to low blood pressure, or hypotension, while taking Zestril.


Q: How long after starting Zestril should a patient expect to see the full therapeutic effect?

A: The initial blood pressure lowering effect typically begins within about one hour after ingestion, with the greatest reduction usually seen approximately six hours later. Consistent daily administration is generally associated with achieving the maximum long-term therapeutic benefit.


Q: Is Zestril considered safe for use during breastfeeding?

A: Official drug labeling and safety documents advise against the use of Zestril while breastfeeding. This recommendation is based on the safety profile and the potential for the medicine to pass to the infant.


Q: What is the eligibility classification for Zestril use in children?

A: Zestril is officially indicated for the treatment of hypertension (high blood pressure) in pediatric patients aged 6 years and older. The medication is not recommended for use in children younger than six years of age.


Q: What is the official information regarding the risk of angioedema in African American patients taking Zestril?

A: Regulatory warnings highlight that patients of African American descent receiving ACE inhibitors have been noted to have a higher risk of developing angioedema compared to non-African American patients. This is a specific safety consideration documented in the official labeling.


Q: What considerations are in place for prescribing Zestril to patients with pre-existing kidney problems?

A: Regulatory documents state that patients with pre-existing kidney problems often require specific dose adjustments based on their kidney function. Close medical supervision and routine monitoring of blood substances like potassium and creatinine are typically recommended.


Q: What are the documented signs of severely low blood pressure (hypotension) while on Zestril?

A: Symptoms that may indicate low blood pressure, or hypotension, while taking Zestril are documented in patient safety materials. These signs include feelings of lightheadedness, dizziness, or the sensation of nearly fainting.


Q: Is it safe to split or crush Zestril tablets if a person has trouble swallowing?

A: Zestril is supplied as an oral tablet. For patients who experience difficulty swallowing, official product information often points to the availability of an alternative oral solution of lisinopril, which is the active ingredient.


Q: What does official guidance say about Zestril use in older adult populations?

A: Official guidance notes that older adult patients may require specific monitoring due to potential differences in how their bodies process the medicine. Particular attention is often paid to their kidney function and potential interactions with other medications, such as NSAIDs.

Advertisements

How should Zestril 5mg be stored and disposed of?

How to Store and Dispose of Zestril 5mg

To maintain the medication's stability, Zestril (lisinopril) tablets must be stored at controlled room temperature, typically 20 C to 25 C (68 F to 77 F). The container must be kept tightly closed to protect the tablets from moisture and excessive heat, and they should be kept from freezing.

Always store this medicine in a location that is out of the sight and reach of children.

When disposing of Zestril, it is essential to protect the environment. You must not throw away this medicine via wastewater or household waste. Instead, consult a pharmacist or local authority for instructions on proper disposal of expired or unused medication. Do not keep outdated medicine.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Zestril 5mg found in:

A-Z Index: